| Literature DB >> 29335451 |
Midori Motokawa1, Satoshi Watanabe1, Akiko Nakatomi1, Tatsuro Kondoh2, Tadashi Matsumoto2, Kanako Morifuji3, Hirotake Sawada4, Toyoki Nishimura4, Hiroyuki Nunoi4, Koh-Ichiro Yoshiura5, Hiroyuki Moriuchi1, Sumito Dateki6.
Abstract
Takenouchi-Kosaki syndrome (TKS) is a congenital malformation syndrome characterized by severe developmental delay, macrothrombocytopenia, camptodactyly, sensorineural hearing loss, and dysmorphic facial features. Recently, a heterozygous de novo mutation (p.Tyr64Cys) in the CDC42 gene, which encodes a key small GTP-binding protein of the Rho-subfamily, was identified in two unrelated patients with TKS. We herein report a third patient with TKS who had the same heterozygous CDC42 mutation. The phenotype of the patient was very similar to those of the two previously reported patients with TKS; however, she also demonstrated novel clinical manifestations, such as congenital hypothyroidism and immunological disturbance. Thus, despite the heterozygous mutation of CDC42 (p.Tyr64Cys) likely being a hot-spot mutation for TKS, its phenotype may be variable. Further studies and the accumulation of patients with CDC42 mutations are needed to clarify the phenotype in patients with TKS and the pathophysiological roles of the CDC42 mutation.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29335451 DOI: 10.1038/s10038-017-0396-5
Source DB: PubMed Journal: J Hum Genet ISSN: 1434-5161 Impact factor: 3.172